Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04080739 · ClinicalTrials.gov registry record · Phase 4

Regional Block for Postoperative Free Flap Care

A Phase 4 study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target

NCT04080739: Completed Phase 4 study, sponsored by University of Alabama at Birmingham.

NCT04080739 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04080739, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this protocol is to evaluate the safety and efficacy of regional anesthesia for head and neck patients undergoing microvascular free flap reconstruction.

Primary Outcome

Opioid Utilization was measured by the number of mg of Oral Morphine Equivalent (oral pain medication) was given to patients.

Interventions

  • DRUG ropivicaine 0.2%

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-01-13
Est. Completion 2022-03-01
Phase Phase 4
University of Alabama at Birmingham

1,160 total trials

What the finished NCT04080739 record still lists

NCT04080739 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which ropivicaine 0.2% is the first listed.

NCT04080739 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04080739 about?

NCT04080739 is a clinical study titled "Regional Block for Postoperative Free Flap Care". The purpose of this protocol is to evaluate the safety and efficacy of regional anesthesia for head and neck patients undergoing microvascular free flap reconstruction.

What is the current status of trial NCT04080739?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2020-01-13. Estimated completion is 2022-03-01.

What interventions are being tested in trial NCT04080739?

The interventions under investigation include: ropivicaine 0.2% (DRUG).

Who is sponsoring clinical trial NCT04080739?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04080739's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04080739, the US trial registry maintained by the National Library of Medicine. NCT04080739 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.